Latest Strategy News

Pacific Lime and Cement Limited has made significant strides in Papua New Guinea, rebranding and advancing key projects while initiating commercial quicklime shipments to Western Australia. The company’s robust cash position and community agreements set the stage for upcoming construction milestones.

Tryptamine Therapeutics has initiated the first-ever clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with patient dosing set to begin shortly and results expected by year-end.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.

Botala Energy has successfully brought new wells online at its Serowe Coal Bed Methane project, significantly boosting reservoir pressure and advancing its LNG development plans. The company also completed Phase 1 of its Bankable Feasibility Study and raised A$1.25 million to fund ongoing exploration and engineering.

RooLife Group (ASX, RLG) reported $1 million revenue in Q4 FY2025, driven by its UK TikTok marketplace launch and a major solar product order from India, while divesting its digital marketing arm and cutting staff costs.

Ragnar Metals confirms multiple Iron Oxide Copper Gold (IOCG) prospects in southern Sweden, expanding its landholding to 159 km² and strengthening its strategic position in gold and critical minerals.

Rapid Critical Metals has completed a $10.5 million capital raise to acquire major silver projects in New South Wales, appointed Byron Miles as Managing Director, and expanded its land holdings near the Webbs Silver Project by 26 times.

MPower Group has entered a binding agreement to sell its renewable energy assets and platform to Wollemi Energy Group for approximately $19 million, marking a pivotal shift in its business strategy.

Aspire Mining Limited has refined its Ovoot Coking Coal Project development plans to reduce upfront capital expenditure, progressing towards mining commencement in Q4 2025 amid positive market feedback and advancing infrastructure contracts.

Oakridge International reported robust revenue growth and expanded its partner network in Q4 2025, underpinning a promising outlook in healthcare technology. The company also advanced product innovation aligned with new industry standards.

Lodestar Minerals has completed a pivotal drilling program at its Darwin Project in Chile, confirming promising gold and copper mineralisation. The company also announced a $2.7 million capital raise to fund ongoing exploration and corporate activities.

Optiscan Imaging Ltd has launched its first in-human breast cancer study and unveiled a new veterinary imaging device, while securing a key US collaboration to support FDA submissions.